Announced Tue, 9 Jun, 2026 · 15:11 IST
Marksans Pharma rating outlook revised to Positive by India Ratings
MARKSANS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+5.1%1-day move
₹236.00
prior close
₹252.99
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.4+0.2+0.2—+5.1+6.2+6.7+5.9+4.4+10.8+13.6+18.1+15.0+39.8
Up moveDown movePending
AI summary
India Ratings and Research has revised the outlook on Marksans Pharma's bank loan facilities of 195.75 crore rupees to Positive from Stable. The existing ratings of IND AA- for long-term and IND A1+ for short-term facilities have been affirmed. A positive outlook signals expected improvement in the company's credit profile going forward.
Likely market impact
Improved credit outlook may reduce future borrowing costs and signals financial strength to investors.